Jessica N McALpine
Jessica N McALpine
University of British Columbia and BC Cancer Agency
Verified email at
Cited by
Cited by
A clinically applicable molecular-based classification for endometrial cancers
A Talhouk, MK McConechy, S Leung, HH Li-Chang, JS Kwon, N Melnyk, ...
British journal of cancer 113 (2), 299-310, 2015
Confirmation of ProMisE: a simple, genomics‐based clinical classifier for endometrial cancer
A Talhouk, MK McConechy, S Leung, W Yang, A Lum, J Senz, N Boyd, ...
Cancer 123 (5), 802-813, 2017
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
S Kommoss, MK McConechy, F Kommoss, S Leung, A Bunz, J Magrill, ...
Annals of Oncology 29 (5), 1180-1188, 2018
Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience
E Hansch, U Chitkara, J McAlpine, Y El-Sayed, MD Dake, MK Razavi
American journal of obstetrics and gynecology 180 (6), 1454-1460, 1999
Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling
A Bashashati, G Ha, A Tone, J Ding, LM Prentice, A Roth, J Rosner, ...
The Journal of pathology 231 (1), 21-34, 2013
Endometrial cancer
EJ Crosbie, SJ Kitson, JN McAlpine, A Mukhopadhyay, ME Powell, ...
The Lancet 399 (10333), 1412-1428, 2022
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ...
Nature genetics 49 (5), 680-691, 2017
TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data
G Ha, A Roth, J Khattra, J Ho, D Yap, LM Prentice, N Melnyk, ...
Genome research 24 (11), 1881-1893, 2014
Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer
A McPherson, A Roth, E Laks, T Masud, A Bashashati, AW Zhang, G Ha, ...
Nature genetics 48 (7), 758-767, 2016
Use of mutation profiles to refine the classification of endometrial carcinomas
MK McConechy, J Ding, MCU Cheang, KC Wiegand, J Senz, AA Tone, ...
The Journal of pathology 228 (1), 20-30, 2012
A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer
LA Brotto, Y Erskine, M Carey, T Ehlen, S Finlayson, M Heywood, J Kwon, ...
Gynecologic oncology 125 (2), 320-325, 2012
Interfaces of malignant and immunologic clonal dynamics in ovarian cancer
AW Zhang, A McPherson, K Milne, DR Kroeger, PT Hamilton, A Miranda, ...
Cell 173 (7), 1755-1769. e22, 2018
Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention
JN McAlpine, GE Hanley, MMM Woo, AA Tone, N Rozenberg, ...
American journal of obstetrics and gynecology 210 (5), 471. e1-471. e11, 2014
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
MK McConechy, J Ding, J Senz, W Yang, N Melnyk, AA Tone, LM Prentice, ...
Modern pathology 27 (1), 128-134, 2014
Molecular classification of grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups
T Bosse, RA Nout, JN McAlpine, MK McConechy, H Britton, YR Hussein, ...
The American journal of surgical pathology 42 (5), 561-568, 2018
Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling
AW Zhang, C O’Flanagan, EA Chavez, JLP Lim, N Ceglia, A McPherson, ...
Nature methods 16 (10), 1007-1015, 2019
Clinicopathological and molecular characterisation of ‘multiple‐classifier’endometrial carcinomas
A León‐Castillo, E Gilvazquez, R Nout, VT Smit, JN McAlpine, ...
The Journal of pathology 250 (3), 312-322, 2020
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
YK Wang, A Bashashati, MS Anglesio, DR Cochrane, DS Grewal, G Ha, ...
Nature genetics 49 (6), 856-865, 2017
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma
CH Lee, WB Ou, A Mariño-Enriquez, M Zhu, M Mayeda, Y Wang, X Guo, ...
Proceedings of the National Academy of Sciences 109 (3), 929-934, 2012
Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease
JY Hou, MG Kelly, H Yu, JN McAlpine, M Azodi, TJ Rutherford, ...
Gynecologic oncology 105 (1), 211-217, 2007
The system can't perform the operation now. Try again later.
Articles 1–20